Corona Virus: Commonly Followed Treatment Regimen, an Updated Follow-Up on Trending Perspectives

The present article is based on the different treatment regimen in Figure 1 based on the severity of infection. ABSTRACT Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 or Covid-19, no antiviral agents have yet been shown to be efficacious. Many more anti-viral medicines, antibiotics, minerals, vitamins and flavonoids are being worked upon to attain beneficial after effects. Diligent efforts for the development of vaccines are in their developing stages. Till then most important is to take the preventive measures and to rely on the available alternates. This update deals with the review of the available medicines, which are being used right now to combat Covid-19.


Testing for Infection
Diagnosis of COVID-19 is essential in order to detect SARS-CoV-2 RNA by Antigen test and by RT-PCR. Detection of SARS-CoV-2 viral RNA is better in nasopharynx samples compared with throat samples. Lower respiratory samples may have better viral yield than upper respiratory samples.SARS-CoV-2 antigen tests can also be used in a variety of testing strategies. SARS-CoV-2 RNA has also been detected in stool and blood. Detection of SARS-CoV-2 RNA in blood may be a marker of severe illness [8].
Prophylaxis: While there is extremely limited data, the mentioned combination may have a role in the prevention of COVID-19 disease. A recent publication suggests that melatonin may reduce the risk of COVID-19 infection, [9] Melatonin, a wellknown anti-inflammatory and anti-oxidative molecule, is protective against virus and other pathogens. Melatonin is effective in critical care by reducing vessel permeability, anxiety and improving sleeping quality, which might also be beneficial for better results for COVID-19 patients. Notably, melatonin has a high safety profile.
Even when melatonin was given at dose of 1 gm. /day for a month in humans, there were no adverse effects of the treatment [10,11].
Many papers suggest that Vitamin D deficiency increases the risk of infection and is associated with a significantly worse result. Vitamin D favorably corrects host responses to severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2, both in the early viraemic and later phases of COVID-19. Vitamin D metabolites have been known to promote innate antiviral mechanisms [12][13][14]. Lower has to be worked upon its consequences [15,16].
Vitamin C: Low dose (0.5-2 g/d) of it may have benefits when used early in severe acute respiratory syndrome coronavirus 2 infections. 500 mg twice daily is extremely helpful. Vitamin C especially at high doses can reduce mediators such as interleukin-6 and endothelin-1. Thus, vitamin C also helps with severe late-stage coronavirus disease 2019. Vitamin C, as an essential micronutrient for humans and as free radical scavenger, is beneficial for severe viral respiratory tract infections [17]. It is known to support various cellular functions of both innate and adaptive immune systems, including adapting vulnerability to various viral infections [18,19]. In chick embryo tracheal organ cultures, vitamin C, was found to increase resistance to infection by a coronavirus [20][21][22].
As an anti-oxidant, the vitamin might help to protect cells from free radicals damage. Vitamin C supplements on regular usage shortens the common cold duration [23]. It is likely that this antiviral effect is why vitamin C is a possible treatment of COVID-19 [24].
Quercetin: 3,3′,4′5,7-pentahydroxyflavone, is a widely distributed plant flavonoid, found in several vegetables, leaves, seeds, and grains, where it combines with sugars to form quercetin glycosides. Studies suggest that quercetin supplementation promotes antioxidant, anti-inflammatory, antiviral, and immunoprotective consequences [25]. Quercetin has been studied in various types and models of viral infection due to its antiviral properties in inhibiting polymerases, proteases, reverse transcriptase and binding viral capsid proteins [26,27].

Symptomatic Patients Care at Home
Famotidine: H2 receptor blocker FAMOTIDINE came to limelight due to its role in reducing the symptoms of COVID-19 patients. A lower peak ferritin value among users of famotidine, supported the hypothesis that its use may decrease cytokine release in the setting of SARS-CoV-2 infection. A randomized controlled trial is currently is under process to prove whether famotidine can improve clinical aspects in hospitalized patients with COVID-19 [28]. Famotidine is one of the highest-ranked matches for drugs predicted to bind 3CLpro,3 receptor, a SARS-CoV-2 protease that generates non structure proteins critical to viral replication as per molecular modeling concepts [28]. Famotidine is known to inhibit human immunodeficiency virus replication without affecting lymphocyte viability [29,30]. Magnesium: Magnesium supplementation has been shown to act against variety of disorders or diseases related to respiratory system, reproductive system, nervous system, digestive system, and cardiovascular system, diabetes and cancer. Serum magnesium level in COVID-19 patients need to be monitored. Mg supplementation reduces CRP levels in individuals with inflammation of CRP levels > 3 mg/dL. In a recent study, it has been shown that Mg supplementation diminishes disease severity and accelerates speedy recovery [46][47][48].

Future Prospects
A vaccine for the coronavirus will likely be ready by early 2021 but rolling it out safely across India's 1.3 billion people will be the country's biggest challenge in fighting its surging epidemic. India's indigenous vaccine developers Bharat Biotech International Ltd.
are at the second-phase human trial stage and Zydus Cadila is in the process to receive approvals for conducting third-phase clinical trials. Till then the preventive steps have to be followed fully, in order to get protected from Covid-19.

Conclusion
Although SARS-CoV-2 can be deadly, it has mild-mannered cousins called seasonal coronaviruses that are among the causes of the common cold. Some scientists have suggested that people might be shielded from SARS-CoV-2 infection if they have recently been infected by a seasonal coronavirus. Till the vaccine development as well as its availability, it is most important is to take the necessary precautions and to use the available alternates.